title: Mapping Uncertainties in the Upstream: The Case of PLGA Nanoparticles in Salmon Vaccines.
abstract: The diversity of nanotechnologies and of the governance challenges that their applications raise calls for exploration and learning across different cases. We present an Upstream Oversight Assessment (UOA) of expected benefits and potential harms of nanoparticles made of a synthetic polymer (PLGA) to improve vaccines for farmed salmon. Suggested by Jennifer Kuzma and colleagues, an UOA may help identify and prioritise research needs, and it may support evaluations of the adequacy of relevant existing regulatory frameworks. In this work, the UOA approach is modified and supported with elements from the uncertainty analysis framework developed by Warren Walker and colleagues. Empirically, we draw on relevant available published literature and insights generated in an ongoing nanoparticle salmon vaccine project, in which one of the authors participates. Nanotechnologies have not previously been encountered in the regulatory context of fish vaccines, which in part raises unique challenges due to prospective large scale vaccine use in semi-open aquatic systems. Strengthened through cooperation between ELSA and technology researchers we found the UOA useful for an early mapping of benefits and concerns, and for identifying areas in need of further research prior to a nanoparticle based salmon vaccine is developed and taken into use. We consider our approach to represent one among several complementing initiatives that seek to contribute to early stage evaluations of possible negative side effects, broadly conceived, in order to facilitate a more robust nanotechnology development.
authors: Kåre Nolde
authors: KN
authors: Nielsen
authors: Børge Nilsen
authors: BN
authors: Fredriksen
authors: Anne Ingeborg
authors: AI
authors: Myhr
references: Nanoethics. 2011 Apr;5(1):87-98
references: 21603038
references: Biol Reprod. 1983 Feb;28(1):186-95
references: 6830939
references: Nat Nanotechnol. 2007 Aug;2(8):469-78
references: 18654343
references: Biomaterials. 2009 May;30(14):2790-8
references: 19232712
references: Vaccine. 1997 Jul;15(10):1070-8
references: 9269049
references: BMC Biol. 2010 Apr 12;8:37
references: 20385031
references: Fish Shellfish Immunol. 2011 Jan;30(1):109-17
references: 20920584
references: Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15850-5
references: 20733076
references: J Control Release. 2011 May 10;151(3):278-85
references: 21223984
references: Sci Total Environ. 2008 Dec 15;407(1):185-96
references: 18822444
references: Vet Immunol Immunopathol. 1999 Dec 15;72(1-2):203-12
references: 10614510
references: Int J Nanomedicine. 2008;3(2):133-49
references: 18686775
references: J Immunol. 2008 Oct 1;181(7):4807-14
references: 18802084
references: Expert Rev Mol Diagn. 2009 May;9(4):325-41
references: 19435455
references: Nat Immunol. 2006 Oct;7(10):1116-24
references: 16980980
references: Dev Biol Stand. 1997;90:383-7
references: 9270867
references: Risk Anal. 2008 Aug;28(4):1081-98
references: 18627547
references: Nat Rev Microbiol. 2010 Jan;8(1):62-73
references: 19966816
references: J Infect Dis. 2008 May 15;197(10):1427-35
references: 18419577
references: Int Immunopharmacol. 2008 Jun;8(6):900-8
references: 18442796
references: Nature. 1998 Mar 19;392(6673):245-52
references: 9521319
references: J Control Release. 2003 Sep 19;92(1-2):173-87
references: 14499195
references: Risk Anal. 2004 Dec;24(6):1515-27
references: 15660608
references: Rev Sci Tech. 2007 Aug;26(2):339-50
references: 17892156
references: Sci Total Environ. 2008 Feb 1;390(1):23-34
references: 17988720
references: Vaccine. 2010 May 21;28(23):3888-95
references: 20371391
references: Int J Pharm. 2003 Jun 18;259(1-2):115-27
references: 12787641
references: Chem Pharm Bull (Tokyo). 1988 Mar;36(3):1095-103
references: 3136939
references: Br J Plast Surg. 2005 Jun;58(4):547-9
references: 15897041
references: Int J Pharm. 2008 Feb 12;349(1-2):249-55
references: 17875373
references: Fish Shellfish Immunol. 2004 May;16(5):633-44
references: 15110337
references: Nanomedicine (Lond). 2008 Oct;3(5):605-8
references: 18817463
references: Biomaterials. 1996 Jan;17(2):93-102
references: 8624401
references: Expert Rev Vaccines. 2005 Feb;4(1):89-101
references: 15757476
references: Fish Shellfish Immunol. 2010 Feb;28(2):320-5
references: 19922799
references: J Immunother. 2007 May-Jun;30(4):378-95
references: 17457213
references: J Microencapsul. 2006 Nov;23(7):782-92
references: 17123922
references: Environ Sci Technol. 2010 Sep 1;44(17):6532-49
references: 20687602
references: Biomaterials. 2001 Feb;22(3):231-41
references: 11197498
references: Annu Rev Immunol. 2005;23:651-82
references: 15771583
references: Nature. 2009 Nov 26;462(7272):449-60
references: 19940915
references: J Drug Target. 2003;11(8-10):495-507
references: 15203918
references: Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):4942-6
references: 8506338
references: Dev Biol (Basel). 2005;121:55-74
references: 15962470
references: Dev Biol Stand. 1997;90:107-16
references: 9270839
references: Adv Drug Deliv Rev. 1997 Oct 13;28(1):5-24
references: 10837562
references: Vaccine. 2008 Mar 20;26(13):1626-37
references: 18295941
references: Dev Biol Stand. 1997;90:341-6
references: 9270862